PubMed

Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells.

Rao SP, Rechsteiner MP, Berger C, Sigrist JA, Nadal D, Bernasconi M.

Mol Cancer. 2007 Jan 10;6:3.PMID: 17214905 [PubMed - indexed for MEDLINE]Related articlesFree article

Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells.

Rechsteiner MP, Berger C, Weber M, Sigrist JA, Nadal D, Bernasconi M.

J Gen Virol. 2007 May;88(Pt 5):1454-9.PMID: 17412973 [PubMed - indexed for MEDLINE]Related articlesFree article

Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection.

Rechsteiner MP, Berger C, Zauner L, Sigrist JA, Weber M, Longnecker R, Bernasconi M, Nadal D.

J Virol. 2008 Feb;82(4):1739-47. Epub 2007 Dec 5.PMID: 18057232 [PubMed - indexed for MEDLINE]Related articlesFree article

Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells.

Leao M, Anderton E, Wade M, Meekings K, Allday MJ.

J Virol. 2007 Jan;81(1):248-60. Epub 2006 Oct 11.PMID: 17035311 [PubMed - indexed for MEDLINE]Related articlesFree article

Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas.

Feng WH, Hong G, Delecluse HJ, Kenney SC.

J Virol. 2004 Feb;78(4):1893-902.PMID: 14747554 [PubMed - indexed for MEDLINE]Related articlesFree article

Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.

Westphal EM, Mauser A, Swenson J, Davis MG, Talarico CL, Kenney SC.

Cancer Res. 1999 Apr 1;59(7):1485-91.PMID: 10197618 [PubMed - indexed for MEDLINE]Related articlesFree article

Epstein-barr virus (EBV) nuclear protein 2-induced disruption of EBV latency in the Burkitt's lymphoma cell line Akata: analysis by tetracycline-regulated expression.

Fujiwara S, Nitadori Y, Nakamura H, Nagaishi T, Ono Y.

J Virol. 1999 Jun;73(6):5214-9.PMID: 10233991 [PubMed - indexed for MEDLINE]Related articlesFree article

Aspirin induces lytic cytotoxicity in Epstein-Barr virus-positive cells.

Liu SF, Wang H, Li ZJ, Deng XY, Xiang H, Tao YG, Li W, Tang M, Cao Y.

Eur J Pharmacol. 2008 Jul 28;589(1-3):8-13. Epub 2008 Apr 16.PMID: 18571159 [PubMed - indexed for MEDLINE]Related articles

De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.

Ye J, Gradoville L, Daigle D, Miller G.

J Virol. 2007 Sep;81(17):9279-91. Epub 2007 Jun 27.PMID: 17596302 [PubMed - indexed for MEDLINE]Related articlesFree article

Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.

Westphal EM, Blackstock W, Feng W, Israel B, Kenney SC.

Cancer Res. 2000 Oct 15;60(20):5781-8.PMID: 11059774 [PubMed - indexed for MEDLINE]Related articlesFree article

Lytic cycle switches of oncogenic human gammaherpesviruses.

Miller G, El-Guindy A, Countryman J, Ye J, Gradoville L.

Adv Cancer Res. 2007;97:81-109. Review.PMID: 17419942 [PubMed - indexed for MEDLINE]Related articles

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

Niller HH, Wolf H, Minarovits J.

Autoimmunity. 2008 May;41(4):298-328. Review.PMID: 18432410 [PubMed - indexed for MEDLINE]Related articles

Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.

Wen W, Iwakiri D, Yamamoto K, Maruo S, Kanda T, Takada K.

J Virol. 2007 Jan;81(2):1037-42. Epub 2006 Nov 1.PMID: 17079287 [PubMed - indexed for MEDLINE]Related articlesFree article

Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agents.

Ghosh SK, Forman LW, Akinsheye I, Perrine SP, Faller DV.

Blood Cells Mol Dis. 2007 Jan-Feb;38(1):57-65. Epub 2006 Dec 11.PMID: 17161633 [PubMed - indexed for MEDLINE]Related articlesFree article

The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.

Pang MF, Lin KW, Peh SC.

Cell Mol Biol Lett. 2009;14(2):222-47. Epub 2008 Dec 13. Review.PMID: 19082921 [PubMed - indexed for MEDLINE]Related articles

Immune activation suppresses initiation of lytic Epstein-Barr virus infection.

Ladell K, Dorner M, Zauner L, Berger C, Zucol F, Bernasconi M, Niggli FK, Speck RF, Nadal D.

Cell Microbiol. 2007 Aug;9(8):2055-69. Epub 2007 Apr 5.PMID: 17419714 [PubMed - indexed for MEDLINE]Related articles

H2O2 inhibits BCR-dependent immediate early induction of EBV genes in Burkitt's lymphoma cells.

Osipova-Goldberg HI, Turchanowa LV, Adler B, Pfeilschifter JM.

Free Radic Biol Med. 2009 Oct 15;47(8):1120-9. Epub 2009 Jun 21.PMID: 19540913 [PubMed - indexed for MEDLINE]Related articles

Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma.

Nanbo A, Inoue K, Adachi-Takasawa K, Takada K.

EMBO J. 2002 Mar 1;21(5):954-65.PMID: 11867523 [PubMed - indexed for MEDLINE]Related articlesFree article

Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death.

Inman GJ, Binné UK, Parker GA, Farrell PJ, Allday MJ.

J Virol. 2001 Mar;75(5):2400-10.PMID: 11160743 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of cyclin D2 in Epstein-Barr virus-positive Burkitt's lymphoma cell lines is related to methylation status of the gene.

Sinclair AJ, Palmero I, Holder A, Peters G, Farrell PJ.

J Virol. 1995 Feb;69(2):1292-5.PMID: 7529333 [PubMed - indexed for MEDLINE]Related articlesFree article